Study: Myo-inositol may lower gestational diabetes risk

01/31/2013 | Reuters

Taking myo-inositol supplements may reduce the likelihood of gestational diabetes among pregnant women at risk for the condition, according to a small study in Diabetes Care. Data on 220 pregnant women with a family history of type 2 diabetes showed 6% of those who took myo-inositol supplements in addition to folic acid developed gestational diabetes, compared with 15% of those only given folic acid.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY